background: Human female meiosis is particularly error prone, leading to the generation of aneuploidy, a problem which increases dramatically with advancing age. Despite being of great clinical importance, the genesis of oocyte aneuploidy remains poorly understood. Cumulus cells (CCs) surround oocytes in antral follicles and play a crucial role in regulating their maturation. During this investigation, we aimed to obtain an insight into the follicular environment of oocytes that become aneuploid and identify non-invasive markers of oocyte chromosome status and competence.
Introduction
As well as transmitting the female genetic contribution to the embryo, the oocyte also has responsibility for the provision of the raw materials essential for early preimplantation development. Of particular relevance are the mRNA transcripts and proteins stored in the oocyte, which support the embryo during the first few cellular divisions until activation of its own genome occurs around the 4-8 cell stage.
After meiotic pairing and recombination has taken place in the fetal ovary, the oocytes undergo meiotic arrest and become surrounded by somatic cells and a basal membrane. At the early stages of development these somatic cells have a flattened morphology and are known as pre-granulosa cells (GCs). The differentiation and proliferation of GCs are under paracrine and autocrine control, with oocytesecreted factors having a strong influence on GC gene expression (Su et al., 2008) . Ultimately, two distinct cellular populations area continuous exchange of proteins and metabolites between the two types of cells. These intimate connections allow the CCs to fulfil their vital role in the support and resourcing of the maturing oocyte (reviewed by Feuerstein et al., 2007) .
During oocyte maturation, the events taking place at the preovulatory stage within the cumulus -oocyte complex (COC) are considered to be of critical importance for the fertilization ability of the oocyte (Russel and Robker, 2007) . Specifically, during the LH surge, CCs transmit a maturation-inducing signal from the extra-follicular environment to the oocyte, which in turn resumes meiosis (Hillier, 1994 ; reviewed by Huang et al., 2012) . Additionally, in mice, it has been shown that correct meiotic spindle positioning is regulated via the crosstalk between the oocyte and its surrounding CCs, suggesting that these somatic cells might even have a role in meiosis itself, potentially influencing chromosome segregation (Barrett and Albertini, 2010) .
In the context of assisted reproductive technology (ART), an oocyte is characterized as 'competent' when it is capable of undergoing cytoplasmic and meiotic maturation, achieving activation following fertilization, supporting early preimplantation development and leading to a healthy live birth (Li et al., 2008) . Currently, identification of competent oocytes in ART laboratories is limited to the assessment of a few morphological features, such as the presence of a first polar body (PB), indicative of nuclear maturity. Unfortunately, these criteria provide only a vague indication of the physiology and competence of an oocyte, and are unable to detect serious genetic abnormalities, such as the presence of aneuploidy.
Female meiosis, with its characteristic interruptions of the cell cycle combined with an apparent deficiency or rigidity of the checkpoint mechanisms that usually act to ensure accurate chromosome segregation in other cell types, is associated with a high-error rate, a problem that increases dramatically with advancing age. Two main mechanisms leading to aneuploidy of female origin have been described: the first is observed during both metaphase I (MI) and metaphase II (MII) and involves the non-disjunction of entire chromosomes (Zenzes and Casper, 1992) ; the second involves the premature division (predivision) of a chromosome into its two constituent chromatids, followed by their random segregation during MI and MII (Angell, 1991) . The cytogenetic analysis of large numbers of human oocytes using various methods not only confirmed the presence of both these aneuploidy-causing mechanisms, but also clearly demonstrated the close relationship between advancing female age and increasing abnormality rates. Most studies suggest that the expected oocyte aneuploidy rate for women under the age of 25 years is 5%, increasing to 10-25% by the early 30s and exceeding 50% in the oocytes of women over 40 years (Sandalinas et al., 2002; Kuliev et al., 2003; Pellestor et al., 2003; Fragouli et al., 2006 Fragouli et al., , 2009 Fragouli et al., , 2011b . Despite the high prevalence of oocyte chromosome abnormalities and the serious clinical consequences they entail, the underlying basis of aneuploidy formation and the mechanism of the maternal age effect remain poorly understood.
The presence of lethal chromosome anomalies in oocytes can be accurately detected by PB biopsy followed by cytogenetic analysis using any of a variety of methods [e.g. microarray comparative genomic hybridization (aCGH)]. However, the removal of oocytes from the optimal environment of the incubator, in order for micromanipulation to take place, is likely to entail some cost to them. Additionally, the invasive nature of the biopsy procedure may carry some risk to the subsequent viability of the oocyte and requires highly skilled embryologists, adding to the expense of such procedures. For these reasons, the development of non-invasive methods of oocyte aneuploidy detection is highly desirable. It has been proposed that it may be possible to assess the biology and competence of the oocyte by assessing gene expression in the CCs with which it is so closely associated (Patrizio et al., 2007; Assou et al., 2008 Assou et al., , 2010 Gebhardt et al., 2011; Ouandaogo et al., 2011) .
Gene expression has a fundamental role in the regulation of virtually every aspect of cellular life. Quantification of gene transcripts can therefore give an indication of the various processes occurring within a cell, and may reveal the basis of biological problems, and provide information concerning oocyte and embryo viability (Wells et al., 2005) . The fact that CCs share the same follicular microenvironment as the oocyte and are in close communication with it via gap junctions, suggests that an analysis of this cell type may reveal much about the oocyte with which they are associated. Additionally, the fact that CCs can easily be collected without compromising the oocyte makes them attractive targets for the development of non-invasive assays of oocyte competence. It is possible that the presence of a chromosome error in an oocyte could affect the levels of gene expression and protein production in the surrounding CCs. It is also possible that an inappropriate follicular environment could predispose the oocyte to chromosome errors and leave a characteristic transcriptional footprint in the CCs. This study therefore aimed to compare the gene expression patterns of CCs associated with normal and aneuploid oocytes, gain an insight into the follicular environment of oocytes that become aneuploid and potentially identify novel non-invasive markers of aneuploidy and general oocyte physiology and competence.
Materials and Methods

Patients and samples
This research was conducted using Institutional Review Board approved protocols and with patient signed informed consent. A total of 28 karyotypically normal women participated in this research project. All these women were undergoing ART treatment with or without preimplantation genetic screening (PGS) in three IVF clinics in the USA. These women were aged between 23 and 46 years (average age 32.8 years). Table I shows a summary of the details of this patient group, along with the number of CC samples examined and the type of technique used for mRNA analysis. For patients 7, 24, 25, 26, 27 and 28 (Table I) , the ovarian stimulation protocol consisted of GnRH agonist started in the midluteal phase of the previous cycle and recombinant FSH (rFSH). Subsequent oocyte collection took place as described previously (Fragouli et al., 2010) . For the remaining patients, the employed stimulation protocols were designed according to what the treating clinicians thought would be the most suitable, including a combination of either GnRH agonist or an antagonist with rFSH, with or without human menopausal gonadotrophin. Serum estradiol levels and transvaginal ultrasound were used to monitor the ovarian response. After administration of hCG for the final follicular maturation, the oocytes were collected 36 h later.
Oocyte, PBs and CCs
A total of 26 oocytes (Patients 7, and 24 -28 in Table I ) had their first PBs biopsied and cytogenetically analysed with the use of aCGH. In addition to the PBs, two clumps of CCs were also removed from 13 of the oocytes. One CC sample consisted of part of the outer layer of the COC and the other was taken from the inner layer, in close contact with the oocyte. For the remaining 13 oocytes of this group only the inner layer of CCs was sampled. An additional 38 oocytes (Patients 1-6 and 8 -23 in Table I ) had clumps of CCs removed mostly from the inner CC layer, but no cytogenetic analysis of first PBs took place for this group of samples. Gene expression in a total of 51 CC clumps was assessed using TaqMan low-density arrays (TLDAs) to investigate up to 96 genes per sample, whereas the inner CC layers (26 sets of cell clumps) were used for a more focused realtime PCR experiment assessing just three genes (details described in subsequent sections).
Sample processing
Micromanipulation of PBs and CCs took place in sterile conditions with solutions and equipment treated to remove/inactivate RNA degrading enzymes. Shortly before IVF procedures took place, part of the outer CC layer was removed mechanically with the use of stripper pipettes (51 samples). In some cases (see above) part of the inner layer of CCs was also removed after a brief exposure to hyaluronidase (26 samples). Each CC clump was briefly washed in phosphate-buffered saline (Invitrogen, USA) containing 0.1% w/v polyvinyl alcohol (Sigma, USA) and 0.4 U/ml RNasin Plus RNase inhibitor (Promega, USA). The CC clumps were subsequently transferred to microcentrifuge tubes and then immediately frozen and stored at 2808C until RNA extraction took place. The collection of CCs was performed rapidly so as to minimize mRNA degradation or any induced changes in gene expression. First PBs were biopsied from mature MII oocytes after the removal of CCs and prepared for aCGH analysis as described previously (Fragouli et al., 2011a,b 
aCGH analysis of PBs
The chromosome complement of biopsied first PBs was examined using aCGH. The procedure took place as described in Fragouli et al. (2011a) . Briefly, whole genome amplification was carried out using the SurePlex amplification kit (Rubicon, USA/BlueGnome Ltd., UK) according to the manufacturer's instructions. Amplified DNA from the first PB and previously amplified normal male (46,XY) DNA (SureRef; BlueGnome Ltd) were fluorescently labelled with the use of the Fluorescence Labelling System (BlueGnome Ltd), also according to the manufacturer's instructions. 'Test' PB DNA was labelled in Cy3 and the 'reference' 46,XY DNA was labelled with Cy5. Test and reference DNA co-precipitation, denaturation, array hybridization and post-hybridization washes all took place as suggested by the manufacturer. The hybridization time was 16 h.
Scanning and image analysis and interpretation
A laser scanner (InnoScan 710, Innopsys, Carbonne, France) was used to excite the fluorophores, and to read and store the resulting hybridization images. The MAPIX software (Innopsys, France) was used to control the scanning of the microarray slides. The resulting images were stored in a TIFF format file and were analysed by the BlueFuse Multi analysis software (BlueGnome Ltd), using criteria and algorithms recommended by the manufacturer of the software (Bluegnome Ltd). First PBs and their corresponding oocytes were classified as normal or aneuploid according to these criteria and algorithms (BlueGnome Ltd).
CC RNA extraction
Extraction of RNA for all 51 CC clumps analysed using TLDAs occurred with the use of the PicoPure RNA Isolation kit (Arcturus, UK). The procedure took place as suggested by the manufacturer with a few modifications. The extracted RNA was eluted to a final volume of 15 -30 ml of elution buffer and the sample concentration along with the absorption at 260/280 and 260/230 were measured twice, using a Nanodrop spectrophotometer. All samples were stored at 2808C until the TLDAs analysis was carried out. The Quick Extract RNA extraction kit (Epicentre, Cambio, UK) was employed to extract RNA from the 26 samples composed of inner CC layers. These samples subsequently underwent a smaller scale real-time PCR analysis. The Quick Extract RNA extraction protocol followed was a modified version of that described by the manufacturer. Specifically, the amount of the Quick Extract RNA extraction solution was reduced 10-fold, so as to adjust volumes for the subsequent step of cDNA synthesis. It was not possible to measure the concentrations for this set of samples, as almost the entirety of the extracted RNA was used for cDNA synthesis and real-time PCR.
cDNA synthesis from total RNA RNA was converted to cDNA using the High Capacity cDNA Reverse Transcription kit (Applied Biosystems, UK). In samples with measured concentrations, a total of up to 16 ng of extracted RNA was used per sample. The total sample volume was adjusted to 10 ml with the addition of diethyl pyrocarbonate water. The rest of the reaction included 2 ml of 10× RT buffer, 0.8 ml of 25× dNTP mix (100 mM), 2 ml of 10× RT random primers, 1 ml of MultiScribe Reverse Transcriptase and 4.2 ml of nuclease-free H 2 O per sample. cDNA synthesis took place by incubating the samples at 258C for 10 min and at 378C for 120 min.
CC gene expression analysis via TLDAs
The expression of 96 genes was evaluated in 51 CC clumps (Tables I and II) using TLDAs, a microvolume real-time PCR technology (Applied Biosystems). TLDA analyses took place as described previously (Fragouli et al., 2010) . The customized TLDA cards consisted of 384 (4 × 96) wells pre-loaded with specified sequence detection (TaqMan) probes. The probes included were chosen based upon the results of a previous series of gene expression microarray experiments. The microarray analyses had assessed the relative expression levels of 30 000 mRNA transcripts in CCs surrounding normal and aneuploid oocytes and highlighted 729 genes that displayed apparent alterations in transcript number in CCs associated with chromosomally abnormal oocytes (data not shown). Ninety four of these genes were selected for further analysis using TLDAs (Supplementary data, Table SI ). Additionally, two housekeeping genes, glyceraldhyde-3-phosphate dehydrogenase (GADPH) and hypoxanthinine phopsphoribosyltransferase 1 (HPRT1) were examined. Pre-amplification of cDNA samples took place in a thermocycler, using a pool of all 96 TaqMan assays and TaqMan Preamp Master Mix (×2) (Applied Biosystems). Reactions were prepared as suggested by the manufacturer and pre-amplification occurred under the following conditions: 10 min hold at 958C followed by 14 cycles of 15 s at 958C and 4 min at 608C. Two times TaqMan Gene Expression Master Mix (Applied Biosystems) was used during the final real-time PCR step, which took place using the following set of conditions: 508C for 2 min, 958C for 10 min and 40 cycles of 958C for 15 s and 608C for 1 min. DC t values were determined by normalization to both house-keeping genes, using the RQ SDS manager software (Applied Biosystems). Replicate analyses were performed for every sample, such that the expression of all 96 genes were assessed in each sample four times.
CC gene expression analysis via real-time PCR
A set of smaller scale real-time PCR experiments was used to examine the expression of three genes in the 26 additional samples composed of the inner layer of CCs from oocytes with aCGH PB analysis (Tables I and II) . The examined genes included the tumour protein p53 inducible protein 3 (TP53I3), the splA/ryanodine receptor domain and suppresor of cytokine signalling (SOCS) box containing 2 (SPSB2) and the house-keeping gene HPRT1. Real-time PCR took place with the use of pre-designed TaqMan Gene Expression Assays (Applied Biosystems), which were available for all three genes (TP53I3: Hs00936520_m1; SPSB2: Hs00261880_m1; HPRT1: Hs01003267_m1). Triplicate amplification reactions were set up for all three genes in each of the 26 CC samples. Each reaction contained 2 ml of cDNA, 7 ml of nuclease-free H 2 O, 10 ml of TaqMan Gene Expression Master Mix (Applied Biosystems) and 1 ml of the 20× TaqMan Gene Expression Assay (Applied Biosystems), for a total volume of 20 ml. The thermal cycler used was a StepOne Real-Time PCR System (Applied Biosystems), and the following conditions were employed: incubation at 508C for 2 min, incubation at 958C for 10 min and then 45 cycles of 958C for 15 s and 608C for 1 min.
Statistical analysis
The TLDA data obtained were first normalized against the two housekeeping genes GADPH and HPRT1. Subsequently, RealTime StatMiner TM version 3 software (Integromics TM SL, Spain) was employed for TLDA data analysis. Simple t-tests were also used to compare the expression of the 94 selected genes in CCs coming from normal and aneuploid oocytes. Additionally, a two-tailed t-test was employed when the expression of TP53I3 and SPSB2 was compared between CCs derived from aneuploid oocytes and normal oocytes. The same approach was used to assess the expression of these two genes in CCs associated with oocytes that led to live births and those that failed to implant. For the smaller scale realtime PCR experiments, the DC t values for TP53I3 and SPSB2 were determined by normalizing against the house-keeping gene (HPRT1) and were further analysed with the use of the StepOne Software v2.1 (Applied Biosystems) as well as with the use of a two-tailed t-test.
Results
Cytogenetic analysis of polar bodies
Microarray CGH (aCGH) was employed for the comprehensive cytogenetic examination of a total of 26 first PBs. The corresponding MII oocytes were generated by six women whose average age was 39 years (age range: 30-46 years). These women were undergoing ART procedures either due to male factor or tubal infertility (i.e. no ovarian involvement was present) with or without PGS. The obtained molecular karyotypes were used to separate the CC clumps (outer and/or inner layers) into two groups, one including samples removed from MII oocytes characterized as haploid normal (23,X), and another including samples removed from chromosomally abnormal oocytes. Table II shows the cytogenetic results obtained after the aCGH analysis of the 26 first PBs. A total of 10 first PBs and therefore their corresponding oocytes were characterized as being aneuploid, with the remainder being classified as normal. Thorough analysis of the aCGH data confirmed the presence of two separate mechanisms leading to aneuploidy of female origin, whole-chromosome non-disjunction and unbalanced chromatid predivision. Nine of the 22 errors scored were due to the malsegregation of entire chromosomes while the remainder were attributed to the unbalanced predivision of single chromatids. Chromosomes of all sizes were found to participate in aneuploidy events, and losses as well as gains were seen.
TLDA analysis of outer CC layers from normal and aneuploid oocytes
Gene expression in a set of 13 outer CC layers was examined. Seven clumps of CCs were removed from MII oocytes whose molecular karyotypes were shown to be 23,X (normal) via aCGH (age range: 36 -46 years, mean 40.0 years), whereas the remaining six CC clumps were associated with aneuploid oocytes (age range: 36-46 years, mean 39.7 years). Details of the chromosome errors scored in the corresponding first PBs are shown in Table II . These oocytes were generated by four of the participating patients (24, 25, 26 and 28 in Table II) .
Comparisons took place to determine whether the chromosomal status of the oocytes affected the quantities of specific gene transcripts in CCs. Of the 94 selected genes, 58 showed expression profiles that were confirmatory of the initial microarray data. Forty nine of the 58 genes were under-expressed in the CCs removed from aneuploid oocytes, whereas the remainder were over-expressed. In many cases, the effect of chromosome errors appeared to be relatively weak; however, two genes not only showed a significant difference in expression associated with oocyte aneuploidy (P , 0.05), but also had relatively large mRNA copy number fluctuations (fold change .2-fold). Both of these genes, TP53I3 and SPSB2, were underexpressed in the CCs surrounding aneuploid oocytes. Classification of both these genes according to molecular function and biological process was accomplished using the PANTHER tool (Applied Biosystems), a database that contains a reference list of all known human genes. Hence, TP53I3 was classified as a dehydrogenase involved in the regulation of carbohydrate metabolism and apoptosis, whereas SBSB2 was classified as a signalling molecule participating in cell-surface mediated signal transduction, intracellular signalling and ubiquitination.
Real-time time PCR analysis of inner CC layers from normal and aneuploid oocytes
To further investigate the expression of both TP53I3 and SPSB2 in CCs of normal and chromosomally abnormal oocytes, a series of more focused real-time PCR experiments were carried out, concentrating on the analysis of the layers of CCs closest to the oocyte. Results were obtained for a total of 21 inner CC layers, 14 of which were removed from chromosomally normal MII oocytes (mean female age 38.6 years) and the remaining 7 from aneuploid oocytes (mean female age 40.1 years). Delta C t 's (DC t ) were calculated by subtracting the C t of either TP53I3 or SPSB2 from the C t of the house-keeping HPRT1 gene for each of the CC samples. These DC t values are shown in Table III , and for the CCs of aneuploid oocytes ranged from 0.5 to 2.6 for TP53I3 and 4.1 to 6.9 for SPSB2, while for the CCs of the chromosomally normal oocytes they varied from 21.2 to 2.2 for TP53I3 and 1.2 to 7.1 for SPSB2. Lower DC t values correspond to higher levels of gene expression, whereas high DC t values are associated with lower numbers of mRNA transcripts. The real-time PCR data was concordant with the results obtained from outer CC layers obtained using TLDAs. Both genes were downregulated in the inner CC layers of aneuploid oocytes, and up-regulated in 8 of the 14 inner CC layers taken from normal MII oocytes. There were, however, six CC samples (7-1, 7-3, 25-2, 25-4, 26-3 and 28-1) removed from apparently normal oocytes, for which both SPSB2 and TP53I3 had an expression profile similar to that seen for CCs associated with aneuploid oocytes. The expression patterns seen for SPSB2 and TP53I3 in CCs of normal and aneuploid oocytes are illustrated in the graph of Fig. 1 . Although CC gene expression analysis was not able to achieve a perfect classification of the corresponding oocytes into 'normal' and 'aneuploid' categories, a degree of separation was achieved. In the case of TP53I3, expression tended to be significantly lower among CCs associated with aneuploid oocytes (P ¼ 0.01, two-tailed t-test). A non-significant trend towards lower expression was observed for SPSB2 (see Supplementary data, Fig. S1 ).
CC expression of SPSB2 and TP53I3 and clinical outcome
As well as assessing the expression of SPSB2 and TP53I3 in relation to oocyte aneuploidy, we were able to evaluate whether mRNA transcript levels for these two genes were associated with clinical outcome (i.e. the establishment of a pregnancy leading to a healthy live birth). The expression of SPSB2 and TP53I3 was assessed in a new set of 38 outer CC layers, which were examined using TLDAs. The 38 CC samples were derived from oocytes which produced embryos that were transferred without any chromosome screening. The embryos were generated by 22 women (Patients 1-6 and 8-23 in Table I ). All cycles involved either single embryo transfer, transfer of two embryos followed by no pregnancy or transfer of two embryos followed by birth of dizygotic twins. Thus, the ultimate fate of each transferred embryo was known. Analysis of gene expression in relation to clinical outcome took place in a blinded manner. A total of 18 of the transferred embryos implanted successfully and resulted in healthy live births (mean female age of 32.0 years), while no pregnancy ensued after the transfer of the remaining 20 embryos (mean female age of 30.4 years). The day of transfer varied depending on embryo quality from Days 3 to 5. The expression profiles of TP53I3 and SPSB2 were compared between the CCs of embryos which led to live births and those who failed to implant. Of the two genes, SPSB2 showed the clearest association with successful pregnancy, tending to be up-regulated in the CCs of oocytes which led to live births. These differences in expression between the two sample groups approached statistical significance (P ¼ 0.054 two-tailed t-test), and are illustrated in the box plot shown in Fig. 2 .
Discussion
During the course of this study, we examined the transcriptome of CCs in relation to oocyte aneuploidy and clinical outcome. For this purpose, we combined a comprehensive molecular cytogenetic method for oocyte evaluation with three different types of gene expression experiments (microarrays, TLDAs and real-time PCR) for the analysis of CC transcripts. The data obtained using this strategy provided, for the first time, an insight into the follicular microenvironment of oocytes that acquire chromosome errors and revealed novel biomarkers of aneuploidy of potential clinical significance.
CCs are biologically distinct from other follicular cells and perform various specialized roles so as to support the oocyte in its growth and maturation. The CCs receive and transmit endocrine (and other) signals within the ovary and provide vital resources for the growing oocyte. For example, they metabolize glucose (glycolysis) and supply clinical outcome. This gene had a tendency to be up-regulated in CCs removed from oocytes which were able to produce healthy live births and also tended to be down-regulated in CCs removed from oocytes which did not produce clinical pregnancies (P ¼ 0.054 two-tailed t-test). The lines indicate the minimum and maximum values, with the extend of the boxes representing the first and third quartiles (i.e. the values into which half of all results fall).
pyruvate to the oocyte for its energy requirements (reviewed by Sutton-McDowall et al., 2010) . They also provide the amino acids and nucleotides necessary for the synthesis of macromolecules such as ribosomal and messenger RNAs (reviewed by Johnson, 2007; Huang and Wells, 2010) . Nutrients and other substrates generated in the CCs can be transferred to the oocyte via transporters or through gap junctions. Gap junctions are located on transzonal projections, cytoplasmic processes extending from the CCs, piercing the zona pellucida and terminating at the plasma membrane of the developing oocyte. It is thought that the oocyte actively participates in the regulation of CC metabolism, via feedback loops established between the two types of cells (Gilchrist et al., 2008; Su et al., 2008) .
A set of preliminary microarray experiments that analysed more than 30 000 distinct mRNA transcripts in CCs associated with chromosomally normal and abnormal MII oocytes, revealed 700 genes with apparent differences in expression related to aneuploidy (data not shown). Ninety four of these genes (plus two house-keeping reference genes) were chosen for further investigation (Supplementary data, Table SI ) and their expression levels evaluated using real-time PCR, the method considered to provide the most reliable quantification of mRNA transcript levels. The gene expression patterns of 13 samples composed of cells from the outer layers of the cumulus mass were assessed using TLDAs. This real-time PCR strategy involved the use of microfluidic cards and amplification in minute volumes. So despite the very small size of the CC samples, it was possible to evaluate the expression levels of all 96 genes. Seven of the CC samples surrounded chromosomally normal oocytes, while the remaining six were associated with chromosomally abnormal gametes. Of the 94 candidate genes examined, a total of 58 had expression profiles that were consistent with the preliminary microarray analysis. What was evident from both sets of obtained data (microarray and TLDA analysis) was that the CCs that enclose aneuploid oocytes tend to be less transcriptionally active and therefore possibly not as proliferative, compared with CCs that surround normal oocytes. Lower quantities of RNA were obtained from such samples and are shown in Supplementary data, Table SII. A general reduction in mRNA content has been described in other studies that assessed the transcriptomic activity of CCs in relation to oocyte competence and clinical outcome, although none specifically addressed the issue of aneuploidy. Assou et al. (2008) used a combination of microarray and real-time PCR analyses to identify specific patterns of CC gene expression associated with embryo morphology (a key indicator of viability) and pregnancy outcome. It was observed that CCs removed from oocytes that led to successful pregnancies had the majority of their genes up-regulated (Assou et al., 2008) . Another investigation examining the expression of a total of 12 genes in CC samples via real-time PCR concluded that embryos capable of implanting and leading to live births exhibited a higher expression of at least three of the examined genes (Gebhardt et al., 2011) .
The TLDA results from the current study demonstrated that the presence of aneuploidy in the enclosed oocyte was associated with the abnormal expression of the genes involved in metabolic processes, intracellular and membrane transport, hypoxia and apoptosis in the surrounding CCs (Supplementary data, Table SI ). Together, these findings suggest that the follicular microenvironment in which aneuploid oocytes mature may be suboptimal (e.g. hypoxic and/or poorly resourced). Metabolism and synthetic processes in transcriptionally quiescent CCs are likely to be less active, meaning a reduced amount of energy substrates and other molecules being transported into the oocyte during its maturation. This is predicted to have a detrimental effect on a wide variety of critical cellular functions, of which accurate chromosome segregation is one. Problems with the follicular environment may also be associated with an inappropriate transmission of signals to the oocyte, allowing the resumption of meiosis in an oocyte that has not reached full cytoplasmic maturity and is ill-prepared to segregate its chromosomes.
Of the 58 genes whose profiles were confirmed after TLDA analysis, most had a statistically significant (P , 0.05) differential expression between CCs of normal and aneuploid oocytes, but in many cases the extent of the changes in their mRNA transcript number was small. We did, however, identify two genes that were differentially expressed in a statistically significant manner between the two sets of samples and also had more obvious changes in their levels of expression (.2-fold). These were SPSB2 and TP53I3, both of which were downregulated in the CCs associated with aneuploid oocytes.
SPSB2 belongs to the SOCS box family of E3 ubiquitin ligases and functions as an adaptor protein in the E3 ubiquitin ligase complex. This complex ubiquitinates the inducible form of nitric oxide synthase (iNOS), targeting it for proteosomal degradation (Kuang et al., 2010) . In CCs associated with chromosomally abnormal oocytes, the reduced expression of this gene could lead to the accumulation of excessive amounts of abnormal/redundant proteins, the presence of which would hamper multiple cellular processes. Another possible effect is that there might be an increase in the levels of reactive oxygen species in and around the oocyte due to raised levels of nitric oxide produced as a consequence of over-activity of iNOS.
TP53I3 is a downstream target for p53 and a crucial component of the DNA damage response pathway, as it is directly involved in transmitting the signal from damaged DNA to the intra-S and G 2 /M checkpoint machinery in humans (Lee et al., 2010) . Down-regulation of TP53I3 could lead to a reduction in the DNA damage response and in turn to altered activity of various associated processes such as apoptosis. The latter could result in the perpetuation of dysfunctional CCs, unable to transmit appropriate signalling to/from the developing oocyte. A recent study has shown that the oocyte-secreted factors bone morphogenetic protein 6 (BMP6) and BMP15 act to protect the surrounding CCs from apoptosis, by establishing a morphogenic paracrine gradient of BMPs and influencing steroidogenesis (Hussein et al., 2005; Ebeling et al., 2011) .
The difference in rates of CC apoptosis, previously reported to be associated with oocyte quality (Høst et al., 2002) , and the link between aneuploidy and expression of genes associated with DNA repair and apoptosis, reported here, could be a consequence of a chromosomally abnormal oocyte failing to establish a suitable paracrine gradient of BMPs or other signalling molecules (i.e. altered expression and apoptosis in CCs are caused by the abnormal oocyte). However, it is also possible that the observed changes in gene activity and apoptosis could be a consequence of an imperfect follicular environment rather than the influence of an abnormal oocyte. A poor environment, whether hormonally deprived or hypoxic, could impact the oocyte directly, leading to aneuploidy and/or other cellular problems. If this is the case, then the alterations seen in CCs may be a consequence of shared environmental conditions that predispose an oocyte to meiotic error (i.e. oocyte aneuploidy is independent of altered CC gene expression, but both are induced by the same environmental disruption). Alternatively, the abnormal environment could cause a dysfunction of the CCs, leading them to fail in their task of supporting the oocyte and communicating signals to it. This may result in an elevated risk of chromosomal malsegregation during meiosis (i.e. oocyte aneuploidy is caused by altered CC gene expression, which in turn results from inappropriate microenvironmental conditions in the ovary). It is not yet clear which of these mechanisms is correct.
The CC expression of both SPSB2 and TP53I3 was also examined in relation to clinical outcome. This part of the study took place in a blinded manner using a set of 38 CC samples removed from embryos that were transferred without any chromosome screening. The results obtained indicated that both genes had a tendency towards greater activity in CCs associated with oocytes that, after fertilization, produced a healthy live birth. The association was clearest for SPSB2, which approached statistical significance (P ¼ 0.054). Although aneuploidy may well be the single most important determinant of oocyte competence, responsible for many cases of implantation failure and miscarriage, there are other factors that also contribute to embryo potential, both oocyte and sperm derived. Consequently, it is expected that some oocytes that are chromosomally normal will nonetheless fail to produce a viable pregnancy. Given this confounding effect, it is striking that an apparent difference in SPSB2 expression related to live birth was seen.
We further evaluated the transcriptomic activity of SPSB2 and TP53I3 with the use of a set of smaller scale real-time PCR experiments. This set of real-time PCR experiments was carried out in an attempt to assess the feasibility of developing a rapid, inexpensive, non-invasive diagnostic assay. Twenty-one inner CC layer clumps (CCs in direct contact with the oocyte) analysed for this part of the investigation yielded data (14 from normal oocytes and 7 from abnormal). In general, the data obtained were confirmatory of the TLDA analysis, i.e. the real-time PCR analysis clearly showed that both SPSB2 and TP53I3 were down-regulated in all seven inner layer CC clumps removed from aneuploid oocytes; both genes were up-regulated in eight inner layer CC clumps removed from normal oocytes. However, there were six inner CC layers, removed from chromosomally normal (23,X) MII' oocytes, for which both genes had an expression profile similar to that seen for the CCs of aneuploid samples (Fig. 1) . Importantly, despite this overlap, the distribution of gene expression results remained significantly different between CCs associated with normal and aneuploid oocytes (P ¼ 0.01).
One possible hypothesis explaining why a few chromosomally normal oocytes had patterns of CC gene expression resembling aneuploid oocytes is that they acquired a chromosome anomaly during meiosis II, which is not completed until after fertilization. As second PBs were not available for aCGH analysis during this study, we were unable to confirm this. Another possibility is that the oocytes with 'abnormal' patterns of gene expression may have been at elevated risk of malsegregating their chromosomes, but on this occasion managed to complete meiosis without an error occurring. It is unknown whether such high-risk oocytes have a normal capacity to support early embryonic development or whether the predisposition to aneuploidy is symptomatic of a more far reaching deficiency, precluding successful development regardless of ultimate chromosomal status. A third possibility is that subtle differences in patient characteristics or the methods used to treat them could have induced changes in gene expression, causing CCs associated with chromosomally normal oocytes to cluster with those from aneuploid oocytes. While it is not possible to entirely rule this out, we were unable to detect any obvious differences in the patients whose samples were affected, or in the treatment they received. It is also possible that these six oocytes were removed from an abnormal follicular environment just in time, i.e. prior to suffering an irreversible chromosome malsegregation error.
In theory, the non-invasive detection of chromosomally abnormal oocytes using CCs could allow a reduction in, or elimination of, PB and/or embryo biopsy for the assessment of aneuploidy. Further research is first needed to define the accuracy rates of approaches based upon analysis of CC gene expression, as described here, and to assess whether or not differences in treatment protocols (e.g. controlled ovarian stimulation) distort the results obtained.
A limitation of the proposed strategy is that, unlike current methods of oocyte/embryo cytogenetic evaluation (e.g. microarray-CGH, single nucleotide polymorphism-microarrays, etc.), it does not provide a simple 'normal' or 'aneuploid' diagnosis. Instead results provide an indication of aneuploidy risk but are not entirely definitive (although in many cases expression may be so disturbed that it can be safely assumed the oocyte is not compatible with production of a viable embryo). However, the CC gene expression approach also has major potential benefits. The cost of analysis is a fraction of that of alternative invasive methods and the elimination of embryo biopsy would remove any risk to the oocyte/embryo. Additionally, given that the analysis of CCs can be completed within 4 h, it should be possible to detect abnormal oocytes before sperm exposure, restricting fertilization to those eggs found to be chromosomally normal. This may serve to reduce ethical concerns over embryo/oocyte screening and also has the potential to reduce the number of embryos cryopreserved by limiting the number of embryos produced.
The data produced during this study have also shed light on pathways with atypical activity in CCs associated with aneuploid oocytes. It is not yet clear whether these changes are induced by the abnormal oocyte itself or are a consequence of a poor follicular microenvironment, which is also responsible for predisposing the oocyte to chromosome malsegregation. However, the identification of these genes and pathways offers the tantalizing possibility of finally understanding the genesis of female meiotic aneuploidy and perhaps even providing targets for interventions, aimed at lessening the risk of aneuploidy occurring, either in vivo or during in vitro oocyte maturation.
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